August 21, 2025 a 07:43 pm

IDXX: Fundamental Ratio Analysis - IDEXX Laboratories, Inc.

Overview of IDEXX Laboratories

IDEXX Laboratories, Inc. operates in a vast healthcare market, developing cutting-edge diagnostic products for animals and water testing. With a stable presence globally, the company's diverse market segments might provide opportunities for steady growth despite market volatility.

Fundamental Rating

IDEXX Laboratories holds a solid fundamental position, reflected by its strengths in Return on Equity and Return on Assets.

Category Score Visualization
DCF 3
ROE 5
ROA 5
Debt to Equity 1
P/E 1
P/B 1

Historical Rating

Analysis of past performance shows consistency in key financial metrics, which might indicate stability.

Date Overall DCF ROE ROA D/E P/E P/B
2025-08-21 3 3 5 5 1 1 1
N/A 0 3 5 5 1 1 1

Analyst Price Targets

Analyst predictions suggest a bullish outlook with significant potential upside, as reflected in the high target price.

High Low Median Consensus
785 640 722 715.67
IDEXX Laboratories Stock Chart

Analyst Sentiment

The consensus among analysts indicates a Buy recommendation, dominated by Buy ratings.

Recommendation Count Visualization
Strong Buy 0
Buy 11
Hold 8
Sell 1
Strong Sell 0

Conclusion

IDEXX Laboratories presents a promising investment opportunity given its strong positioning and consistent fundamental performance. The company’s dedication to innovation in the healthcare diagnostics sector solidifies its potential for long-term growth. However, investors should be mindful of market volatility and economic changes, which might affect future performance. Analyst sentiments underscore a robust outlook, suggesting potential upside in price targets. Overall, the stock appears to offer a balanced risk-reward proposition for informed investors.